A very recent contribution (11) demonstrates that in Asn-depleted cancer cells a translational reprogramming, dependent on the increase of MAPK-interacting kinase 1 (MNK1) and eukaryotic translation initiation factor 4E (eIF4E), promotes enhanced ATF4 translation and, hence, ASNS expression. This evidence concerns the gene ASNS and cancer.